Summary by Futu AI
Aditxt, Inc., a biotech company listed on The Nasdaq Capital Market under the symbol 'ADTX', has filed a prospectus with the SEC detailing a common stock purchase agreement with Seven Knots, LLC. The agreement, dated May 2, 2024, allows for the sale of up to $150 million of Aditxt's common stock to Seven Knots at Aditxt's discretion. As of the prospectus date, no shares have been sold under this agreement. The last reported sale price of Aditxt's common stock was $0.496 per share as of September 10, 2024. The agreement is part of Aditxt's strategy to secure funding for its operations and growth initiatives, which include developing a portfolio of health innovations. The company's approach involves securing, growing, and monetizing innovations...Show More